Redhill Biopharma
RDHL
#10586
Rank
S$6.5 M
Marketcap
S$1.25
Share price
4.79%
Change (1 day)
-46.97%
Change (1 year)

Market capitalization of Redhill Biopharma (RDHL)

Market cap: S$6.5 Million

As of May 2026 Redhill Biopharma has a market cap of S$6.5 Million. This makes Redhill Biopharma the world's 10586th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Redhill Biopharma from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026S$6.5 M-12.68%
2025S$7.45 M-38.03%
2024S$12.02 M-68.3%
2023S$37.93 M121.15%
2022S$17.15 M-90.61%
2021S$0.18 B-54.64%
2020S$0.40 B39.6%
2019S$0.28 B34.19%
2018S$0.21 B47.08%
2017S$0.14 B-43.37%
2016S$0.25 B11.51%
2015S$0.23 B49.61%
2014S$0.15 B60.78%
2013S$96.27 M

End of Day market cap according to different sources

On May 23rd, 2026 the market cap of Redhill Biopharma was reported to be:

S$6.5 Million
by Nasdaq info icon info icon
S$6.5 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
S$135.43 B 2,080,998.84%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$386.83 B 5,943,818.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$131.92 B 2,026,942.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$50.76 B 779,863.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
S$2.06 B 31,651.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel